triethylenephosphoramide has been researched along with carboplatin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beijnen, JH; Huitema, AD; Rodenhuis, S; van Maanen, MJ | 1 |
Beijnen, JH; Dalesio, O; de Jonge, ME; Huitema, AD; Mathôt, RA; Rodenhuis, S | 1 |
Beijnen, JH; de Jonge, ME; Huitema, AD; Rodenhuis, S; van Dam, SM | 1 |
Beijnen, JH; Doodeman, VD; Ekhart, C; Huitema, AD; Rodenhuis, S; Smits, PH | 1 |
1 trial(s) available for triethylenephosphoramide and carboplatin
Article | Year |
---|---|
Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Phosphoramide Mustards; Prodrugs; Thiotepa; Time Factors; Triethylenephosphoramide | 2005 |
3 other study(ies) available for triethylenephosphoramide and carboplatin
Article | Year |
---|---|
Urinary excretion of thioTEPA and its metabolites in patients treated with high-dose cyclophosphamide, thioTEPA and carboplatin.
Topics: Acetylcysteine; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Breast Neoplasms; Carboplatin; Creatinine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Models, Chemical; Neoplasms, Germ Cell and Embryonal; Thiotepa; Time Factors; Triethylenephosphoramide | 2001 |
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thiotepa; Triethylenephosphoramide | 2002 |
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Carboplatin; Chromatography, High Pressure Liquid; Cohort Studies; Cyclophosphamide; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Thiotepa; Triethylenephosphoramide | 2009 |